1. Prevention and Treatment of SARS-CoV2 Infection in People Living with HIV: The Need for Specific Data

   • Natalia A. Díaz
   • Rosa de Miguel
   • the Hospital Clinic COVID-19 in HIV Investigators

   Commentary Open access 28 October 2021 Pages: 1 - 13

   

2. A Systematic Review of Influenza Epidemiology and Surveillance in the Eastern Mediterranean and North African Region

   • Samira Soudani
   • Alireza Mafi
   • Amine Amiche

   Review Open access 08 January 2022 Pages: 15 - 52

   

3. Alternative Treatment Strategies for Secondary Bacterial and Fungal Infections Associated with COVID-19

   • Ritam Das
   • Komal Kotra
   • Urmi Bajpai

   Review Open access 22 November 2021 Pages: 53 - 78

   

4. Correction to: Alternative Treatment Strategies for Secondary Bacterial and Fungal Infections Associated with COVID-19

   • Ritam Das
   • Komal Kotra
   • Urmi Bajpai

   Correction Open access 25 January 2022 Pages: 79 - 80

5. A Modern Perspective on Vaccinating Healthcare Service Providers in India: A Narrative Review

   • Mallavalli Surendranath
   • Ravi Wankhedkar
   • Pavitra Dewda

   Review Open access 13 November 2021 Pages: 81 - 99

   

6. Extending the Reach of Antimicrobial Stewardship to Pediatric Patients

   • Tracy N. Zembles
   • Natasha Nakra
   • Sarah K. Parker

   Review Open access 24 January 2022 Pages: 101 - 110

7. Budget Impact Analysis of Fidaxomicin Versus Vancomycin for the Treatment of Clostridioides difficile Infection in the United States

   • Yiling Jiang
   • Eric M. Sarpong
   • Engels N. Obi

   Original Research 22 July 2021 Pages: 111 - 126

   

8. Correction to: Budget Impact Analysis of Fidaxomicin Versus Vancomycin for the Treatment of Clostridioides difficile Infection in the United States

   • Yiling Jiang
   • Eric M. Sarpong
   • Engels N. Obi

   Correction Open access 16 January 2022 Pages: 127 - 127

9. Modelling and Simulation of the Effect of Targeted Decolonisation on Incidence of Extended-Spectrum Beta-Lactamase-Producing Enterobacterales Bloodstream Infections in Haematological Patients

   • Stefanie Döbele
   • Fulvia Mazzaferri
   • Evelina Tacconelli

   Original Research Open access 19 October 2021 Pages: 129 - 143

   

10. Long-Term Effects of COVID-19 on Health Care Workers 1-Year Post-Discharge in Wuhan

    • Tingting Liao
    • Daquan Meng
    • Yang Jin

    Original Research Open access 23 October 2021 Pages: 145 - 163

    

11. Epidemiology of Viruses Causing Pediatric Community Acquired Pneumonia in Shanghai During 2010–2020: What Happened Before and After the COVID-19 Outbreak?

    • Fei Li
    • Yuhan Zhang
    • Jun Shen

    Original Research Open access 25 October 2021 Pages: 165 - 174

    

12. Study on Pharmacokinetic Interactions Between HS-10234 and Emtricitabine in Healthy Subjects: An Open-Label, Two-Sequence, Self-Controlled Phase I Trial

    • Yeping Luo
    • Wenjing Chen
    • Qi Pei

    Original Research Open access 30 October 2021 Pages: 175 - 186

    

13. Utilization of Colistin Versus β-Lactam and β-Lactamase Inhibitor Agents in Relation to Acute Kidney Injury in Patients with Severe Gram-Negative Infections

    • Casey Doremus
    • Stephen W. Marcella
    • Roger M. Echols

    Original Research Open access 03 November 2021 Pages: 187 - 199

    

14. Does Prolonged Infusion Time Really Improve the Efficacy of Meropenem Therapy? A Prospective Study in Critically Ill Patients

    • Yi-Chang Zhao
    • Yang Zou
    • Miao Yan

    Original Research Open access 06 November 2021 Pages: 201 - 216

    

15. Impact of Underlying Comorbidities on Outcomes of Patients Treated with Ceftaroline Fosamil for Complicated Skin and Soft Tissue Infections: Pooled Results from Three Phase III Randomized Clinical Trials

    • Mark Wilcox
    • Jean Li Yan
    • Michal Kantecki

    Original Research Open access 06 November 2021 Pages: 217 - 230

    

16. Efficacy and Safety of Immunomodulators in Patients with COVID-19: A Systematic Review and Network Meta-Analysis of Randomized Controlled Trials

    • Thundon Ngamprasertchai
    • Rattagan Kajeekul
    • Nantasit Luangasanatip

    Original Research Open access 10 November 2021 Pages: 231 - 248

    

17. Long-Term Mortality and State Financial Support in Invasive Meningococcal Disease—Real-World Data Analysis Using the French National Claims Database (SNIIRAM)

    • Jing Shen
    • Stéphane Bouée
    • Ekkehard C. Beck

    Original Research Open access 17 November 2021 Pages: 249 - 262

    

18. Correction to: Long-Term Mortality and State Financial Support in Invasive Meningococcal Disease—Real-World Data Analysis Using the French National Claims Database (SNIIRAM)

    • Jing Shen
    • Stéphane Bouée
    • Ekkehard C. Beck

    Correction Open access 18 January 2022 Pages: 263 - 264

19. Asymptomatic Human Immunodeficiency Virus-1 Infection with High CD4⁺ T Cell Count Does Not Alter Iron Metabolism or Hepcidin Levels: The Pilot Study

    • Aleksandra Szymczak
    • Malgorzata Zalewska
    • Ewa A. Jankowska

    Original Research Open access 20 November 2021 Pages: 265 - 275

    

20. Potential Impact of Nirsevimab on RSV Transmission and Medically Attended Lower Respiratory Tract Illness Caused by RSV: A Disease Transmission Model

    • Nicolas Voirin
    • Victor Virlogeux
    • Alexia Kieffer

    Original Research Open access 23 November 2021 Pages: 277 - 292

    

21. Early Transfusion of Convalescent Plasma Improves the Clinical Outcome in Severe SARS-CoV2 Infection

    • Eszter Fodor
    • Veronika Müller
    • Zsombor Lacza

    Original Research Open access 24 November 2021 Pages: 293 - 304

    

22. Predictors of Complications Secondary to Infective Endocarditis and Their Associated Outcomes: A Large Cohort Study from the National Emergency Database (2016–2018)

    • Tanveer Mir
    • Mohammed Uddin
    • Ghulam Saydain

    Original Research Open access 24 November 2021 Pages: 305 - 321

    

23. Bloodstream Infection and Endocarditis Caused by Staphylococcus aureus in Patients with Cancer: A Multicenter Cohort Study

    • Sara Grillo
    • Guillermo Cuervo
    • Jordi Carratalà

    Original Research Open access 02 December 2021 Pages: 323 - 334

    

24. Aminoglycoside or Polymyxin Monotherapy for Treating Complicated Urinary Tract Infections Caused by Extensively Drug-Resistant Pseudomonas aeruginosa: A Propensity Score-Adjusted and Matched Cohort Study

    • Inmaculada López Montesinos
    • Silvia Gómez-Zorrilla
    • PROA PSMAR group

    Original Research Open access 03 December 2021 Pages: 335 - 350

    

25. Short-Term Immunogenicity Profiles and Predictors for Suboptimal Immune Responses in Patients with End-Stage Kidney Disease Immunized with Inactivated SARS-CoV-2 Vaccine

    • Sarinya Boongird
    • Piyatida Chuengsaman
    • Jackrapong Bruminhent

    Original Research Open access 03 December 2021 Pages: 351 - 365

    

26. Public Health Impact and Cost-Effectiveness Analysis of Routine Infant 4CMenB Vaccination in Germany to Prevent Serogroup B Invasive Meningococcal Disease

    • Stefan Scholz
    • Magdalena Schwarz
    • Wolfgang Greiner

    Original Research Open access 07 December 2021 Pages: 367 - 387

    

27. Meta-Regression of Herpes Zoster Incidence Worldwide

    • Desmond Curran
    • Andrea Callegaro
    • Barbara P. Yawn

    Original Research Open access 07 December 2021 Pages: 389 - 403

    

28. A Randomized, Double-Blind, Placebo-Controlled, First-in-Human Clinical Trial to Assess Safety, Tolerability, and Pharmacokinetics of LY-CovMab, a Potent Human Neutralizing Antibody Against SARS-CoV-2

    • Qian Zhang
    • Renpeng Zhou
    • Wei Hu

    Original Research Open access 08 December 2021 Pages: 405 - 422

    

29. Outcomes in Patients with Staphylococcus aureus Bacteremia Treated with Dalbavancin in Clinical Trials

    • Pedro L. Gonzalez
    • Urania Rappo
    • Michael W. Dunne

    Original Research Open access 14 December 2021 Pages: 423 - 434

    

30. Dalbavancin in Real Life: Economic Impact of Prescription Timing in French Hospitals

    • Guillaume Béraud
    • Jean-Claude Maupetit
    • Martin Blachier

    Original Research Open access 15 December 2021 Pages: 435 - 449

    

31. Awareness and Epidemiology of Chronic Hepatitis C Virus Infections in Florida

    • Emmanuel Thomas
    • Wei-Han Cheng
    • Qingqing Xu

    Original Research Open access 16 December 2021 Pages: 451 - 462

    

32. Brand-Specific Enhanced Safety Surveillance Study of GSK’s Quadrivalent Seasonal Influenza Vaccine, Conducted During the COVID-19 Pandemic, in Belgium, Germany and Spain, for the 2020/21 Season

    • Gaël Dos Santos
    • Hao Wang
    • Ugo Nwoji

    Original Research Open access 27 December 2021 Pages: 463 - 483

    

33. Sofosbuvir/Velpatasvir for Hepatitis C Virus Infection: Real-World Effectiveness and Safety from a Nationwide Registry in Taiwan

    • Pin-Nan Cheng
    • Lein-Ray Mo
    • TACR investigators

    Original Research Open access 28 December 2021 Pages: 485 - 500

    

34. A Cross-Sectional Concept Elicitation Study to Understand the Impact of Herpes Zoster on Patients’ Health-Related Quality of Life

    • Desirée Van Oorschot
    • Ashleigh McGirr
    • Desmond Curran

    Original Research Open access 07 January 2022 Pages: 501 - 516

    

35. Efficacy and Safety of Omadacycline Versus Linezolid in Acute Bacterial Skin and Skin Structure Infections in Persons Who Inject Drugs

    • Gregory J. Moran
    • Surya Chitra
    • Paul C. McGovern

    Original Research Open access 11 January 2022 Pages: 517 - 531

    

36. Effect of Tocilizumab Treatment on Patients with Coronavirus Disease 2019 and Bacteremia: A Retrospective Cohort Study

    • Masaatsu Kuwahara
    • Misa Kamigaito
    • Jun-ichi Hirata

    Original Research Open access 20 January 2022 Pages: 533 - 541

37. No Statistically Apparent Difference in Antifungal Effectiveness Observed Among Trimethoprim/Sulfamethoxazole Plus Clindamycin or Caspofungin, and Trimethoprim/Sulfamethoxazole Monotherapy in HIV-Infected Patients with Moderate to Severe Pneumocystis Pneumonia: Results of an Observational Multicenter Cohort Study

    • Yinqiu Huang
    • Xiaoqing He
    • Yaokai Chen

    Original Research Open access 20 January 2022 Pages: 543 - 557

    

38. Effectiveness of a 6-Month Isoniazid on Prevention of Incident Tuberculosis Among People Living with HIV in Eritrea: A Retrospective Cohort Study

    • Mulugeta Russom
    • Henok G. Woldu
    • Katia Verhamme

    Original Research Open access 29 January 2022 Pages: 559 - 579

    

39. Sepsis in Pediatric Cancer: Does Gender Matter? A 20-Year Retrospective Study

    • Andreas Meryk
    • Gabriele Kropshofer
    • Roman Crazzolara

    Brief Report Open access 25 October 2021 Pages: 581 - 585

    

40. Lack of Prognostic Value of SARS-CoV2 RT-PCR Cycle Threshold in the Community

    • Miguel J. Martínez
    • Luca Basile
    • Climent Casals-Pascual

    Brief Report Open access 11 November 2021 Pages: 587 - 593

    

41. A Randomized Controlled Trial to Evaluate the Safety and Efficacy of a Novel Inhaled Biologic Therapeutic in Adults with Respiratory Distress Secondary to COVID-19 Infection

    • Michael Roshon
    • Luciano Lemos-Filho
    • David Bar-Or

    Brief Report Open access 14 November 2021 Pages: 595 - 605

    

42. Effect of Previous SARS-CoV-2 Infection on Antibody Response to a Single Immunization with the Pfizer BNT162b mRNA Vaccine Among Healthcare Workers in Foggia, Italy

    • Tobias Homan
    • Francesca Fortunato
    • Domenico Martinelli

    Brief Report Open access 29 December 2021 Pages: 607 - 615

    

43. Antimicrobial Stewardship with and without Infectious Diseases Specialist Services to Improve Quality-of-Care in Secondary and Tertiary Care Hospitals in Germany: Study Protocol of the ID ROLL OUT Study

    • Nicole Zimmermann
    • Rebekka Allen
    • the ID ROLL OUT Study group

    Study Protocol Open access 09 November 2021 Pages: 617 - 628

    

44. Letter to the Editor Regarding Management of Adult Patients with COVID-19 Outside Intensive Care Units: Guidelines from the Italian Society of Anti-Infective Therapy (SITA) and the Italian Society of Pulmonology (SIP)

    • Tommaso Manciulli
    • Michele Spinicci
    • Lorenzo Zammarchi

    Letter Open access 10 December 2021 Pages: 629 - 633

45. A Response to: Letter to the Editor Regarding Management of Adult Patients with COVID-19 Outside Intensive Care Units: Guidelines from the Italian Society of Anti-Infective Therapy (SITA) and the Italian Society of Pulmonology (SIP)

    • Matteo Bassetti
    • Daniele Roberto Giacobbe
    • the Italian Society of Anti-infective Therapy (SITA), the Italian Society of Pulmonology (SIP)

    Letter Open access 10 December 2021 Pages: 635 - 638